The added value of pirfenidone to fight inflammation and fibrotic state induced by SARS-CoV-2

ConclusionIn this article, we consider the role of antifibrotic therapy with pirfenidone in patients with SARS-CoV-2 infection on going or in the stage of postinfection with pulmonary fibrotic consequences. The scientific rationale for its use is also described.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research